Our appraisal of potential stock price performance relative to its Peer Group and the overall stock market is based on three key drivers of value: Growth, Profitability, and Risk. Key Regeneron Pharmaceuticals characteristics: high financial strength, high expected growth, high stability, and average profitability. A big positive influence on Regeneron Pharmaceuticals’ valuation is its superior Growth.
Regeneron Pharmaceuticals has a current Value Trend Rating of B (Positive). Stocks with high Value Trend Ratings are expected to outperform the general market while stocks with low Value Trend Ratings are expected to underperform.
Regeneron Pharmaceuticals’ common shares will need to reach $1585 to achieve average annual stock market performance of 9.0% over the next 6 years. Regeneron Pharmaceuticals’ stock price will need to reach $1866 by 2028 to achieve upper quartile performance. What is the market’s view of Regeneron Pharmaceuticals’ future operating performance as reflected in the current price of $945?
Our appraisal of potential stock price performance relative to its Peer Group and the overall stock market is based on three key drivers of value: Growth, Profitability, and Risk. Key Regeneron Pharmaceuticals characteristics: high financial strength, high expected growth, high stability, and average profitability. A big positive influence on Regeneron Pharmaceuticals’ valuation is its superior Growth.
Regeneron Pharmaceuticals has a current Value Trend Rating of B (Positive). Stocks with high Value Trend Ratings are expected to outperform the general market while stocks with low Value Trend Ratings are expected to underperform.
Be the first to comment